Latest news with #FullAllianceGroup
Associated Press
11-07-2025
- Business
- Associated Press
Full Alliance Group Obtains FDA MOCRA Registration for HOCl Platform
TAMPA, Fla., July 11, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group Inc. (OTC: FAGI) and its fifty one percent owned subsidiary, Aquaox Pure Solutions, LLC, announce two pivotal regulatory achievements that position the company at the forefront of the rapidly expanding hypochlorous acid (HOCl) industry. Market Timing Meets Regulatory Excellence The successful completion of third-party Human Repeat Insult Patch Testing (RIPT) for Aquaox's HOCl Hydrogel and FDA MOCRA registration for Aquaox's HOCl arrives as consumer demand for science-backed, non-toxic personal care solutions reaches unprecedented levels. With 73% of consumers actively seeking products free from harsh chemicals and synthetic preservatives, Aquaox's breakthrough validates the market shift toward gentle, effective alternatives. 'We're not just responding to market trends—we're helping define them,' said Michel Van Schaik, President of Aquaox Pure Solutions. 'While competitors struggle with regulatory compliance and formulation challenges, we've built a platform that delivers both safety and scalability in a market hungry for clean solutions.' Disrupting Traditional Categories Through Innovation Aquaox's FDA MOCRA registration positions the company as a rare turnkey partner capable of supporting private-label brands and healthcare entrepreneurs entering regulated retail channels including Amazon, TikTok Shop, grocery, chain pharmacies and other big box retailers. This regulatory advantage creates significant barriers for competitors while opening lucrative distribution partnerships in a market where compliance increasingly determines market access. The company's proprietary nanobubble HOCl technology addresses critical industry pain points including product stability, shelf-life limitations, and manufacturing consistency—challenges that have historically prevented widespread HOCl adoption despite growing consumer awareness of its benefits. Capturing Multiple High-Growth Verticals Aquaox's platform strategy targets three converging market opportunities: Clean Beauty & Personal Care: The $13.2 billion clean beauty market continues its 9.7% CAGR as consumers abandon traditional antiseptics and alcohol-based products for gentler alternatives. Aquaox's RIPT-certified formulations directly address this shift. E-commerce & Digital-First Brands: With 67% of beauty purchases now influenced by social media, Aquaox's MOCRA compliance enables private-label partners to capitalize on the direct-to-consumer boom across major digital marketplaces. Healthcare & Clinical Applications: The $4.2 billion infection prevention market increasingly demands non-toxic, effective solutions. Aquaox's GMP-compliant manufacturing addresses growing hospital and clinical demand for safer antiseptic alternatives. JusSpray™: Consumer Market Validation The company's flagship consumer product, JusSpray™ ( serves as both revenue generator and market proof-of-concept. This alcohol-free, fragrance-free HOCl spray demonstrates consumer acceptance of advanced hypochlorous formulations while establishing Aquaox's direct-to-consumer capabilities. 'JusSpray™ isn't just a product—it's validation that consumers are ready for science-backed alternatives to traditional sanitizers and skin care products,' added Van Schaik. 'Every bottle sold proves our manufacturing quality and market positioning.' Competitive Moat Through Vertical Integration Unlike competitors focused solely on manufacturing or retail, Aquaox's vertically integrated approach—from proprietary nanobubble technology through FDA-compliant manufacturing to direct consumer sales—creates multiple revenue streams and competitive advantages: Industry Leadership in Emerging Category As traditional antiseptic and personal care companies face increasing regulatory scrutiny and consumer backlash against harsh chemicals, Aquaox has positioned itself as the category leader in next-generation HOCl solutions. The company's comprehensive platform addresses every aspect of the value chain, from technology development through regulatory compliance to market distribution. 'We're not just building a product company—we're building the infrastructure for an entire category,' said Van Schaik. 'While others focus on individual products, we're creating the platform that enables the whole HOCl market to scale.' About the Growing HOCl Market Hypochlorous acid represents one of the fastest-growing segments in both personal care and healthcare, driven by increasing consumer awareness of its safety profile and efficacy. Unlike traditional antiseptics, HOCl is naturally produced by white blood cells and breaks down into salt and water, making it ideal for sensitive skin applications and frequent use scenarios. Cognitive Market Research estimates the HOCl the 2025 Market size to be US $6.852 billion with a projected CAGR of ~5.9% from 2025 to 2033. Investment Positioning Full Alliance Group's investment in Aquaox Pure Solutions represents a strategic play on multiple converging trends: clean beauty adoption, regulatory tightening in personal care, and the shift toward science-backed wellness solutions. The company's early-mover advantage in FDA-compliant HOCl manufacturing positions it to capture significant market share as the category matures. About Aquaox Pure Solutions, LLC Aquaox Pure Solutions is the leading advanced hypochlorous acid manufacturing platform, specializing in ultra-pure, shelf-stable, and clinically validated HOCl solutions. Through proprietary nanobubble technology and GMP-compliant infrastructure, Aquaox serves the growing demand for clean, effective alternatives across medical, consumer, and industrial markets. About Full Alliance Group, Inc. (OTC: FAGI) Full Alliance Group is a diversified holding company focused on scaling high-growth businesses in health, science, and sustainability. Through strategic subsidiaries including Aquaox Pure Solutions, Full Alliance builds market-leading platforms that capitalize on emerging consumer trends while delivering sustainable shareholder value. Investor & Media Contact: Investor Relations [email protected] Consumer Product: B2B Manufacturing: This press release contains forward-looking statements. Market data sourced from industry research reports and company analysis. Media Contact: Full Alliance Group Inc. Investor Relations Gabe Rodriguez, Erelations Group [email protected] (623) 261-9046 Pure Aquaox Solutions, LLC Brett Phillips Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including but not limited to statements regarding future financial performance, business strategy, and plans and objectives for future operations. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such forward-looking statements. A photo accompanying this announcement is available at
Associated Press
02-06-2025
- Business
- Associated Press
Full Alliance Group's Pure Solutions Announces Manufacturing Agreement With Stemtech Corporation for New StemPets(TM) Product Line
TAMPA, FL / ACCESS Newswire / June 2, 2025 / Pure Solutions Inc., a wholly owned subsidiary of Full Alliance Group, Inc. (OTC:FAGI), today announced a strategic manufacturing agreement with Stemtech Corporation (STEK) to produce their newly released StemPets™ product line. This partnership marks a significant expansion of Pure Solutions' manufacturing capabilities and strengthens Full Alliance Group's position in the growing pet wellness market. Under the terms of the agreement, Pure Solutions will handle all manufacturing aspects of StemPets™, Stemtech's innovative stem cell nutrition product specifically formulated for companion animals. Production has already begun at Pure Solutions' state-of-the-art facility in Tampa, Florida. Strategic Expansion into Pet Wellness Market The collaboration comes at a pivotal time as the global pet supplement market continues to experience unprecedented growth, projected to reach $3.9 billion by 2027, according to recent industry analyses. StemPets™ represents Stemtech's entry into this lucrative market segment with a product that leverages their established expertise in stem cell nutrition. 'This manufacturing agreement with Stemtech represents a significant opportunity for Pure Solutions and our parent company, Full Alliance Group, " said Bill Heneghan, COO of Full Alliance Group. 'The pet wellness sector is experiencing remarkable growth, and this partnership allows us to leverage our manufacturing expertise while expanding our footprint in this promising market.' StemPets™ utilizes Stemtech's proprietary blend of natural ingredients designed to support the release of adult stem cells in pets, potentially improving overall health, mobility, and quality of life for companion animals. The product addresses a growing consumer demand for science-backed pet wellness solutions. Manufacturing Excellence and Capacity Pure Solutions brings extensive manufacturing capabilities to this partnership, including advanced production facilities that meet stringent quality control standards. The company's manufacturing processes adhere to Current Good Manufacturing Practice (cGMP) regulations, ensuring consistent product quality and safety. 'Our manufacturing facilities are uniquely positioned to handle the specialized requirements of Stemtech's innovative formulations,' said Natalie Collins, Production Director at Pure Solutions. 'We've invested significantly in both equipment and personnel to ensure we can deliver the highest quality products while maintaining the proprietary aspects of Stemtech's formulations.' The agreement includes provisions for scaled production to meet anticipated demand growth, with initial production runs beginning this quarter. Pure Solutions has implemented dedicated production lines to accommodate the specialized requirements of the StemPets™ formulation. Market Opportunity and Growth Potential The pet supplement industry has seen dramatic growth in recent years, fueled by increasing pet ownership rates and growing consumer awareness of pet health issues. According to industry data, approximately 67% of U.S. households now own pets, with owners increasingly seeking premium wellness products for their animal companions. StemPets™ targets this premium segment with a science-based approach to pet wellness. The product's formulation draws on Stemtech's 20+ years of research and development in stem cell nutrition, adapted specifically for companion animals. 'The pet wellness market represents a natural extension of Stemtech's human wellness product line,' commented Charles S. Arnold, Chief Executive Officer at Stemtech Corporation. 'We selected Pure Solutions as our manufacturing partner because of their demonstrated commitment to quality, their technical capabilities, and their ability to scale production as demand increases.' Market research indicates pet owners are increasingly willing to invest in premium health products for their companions, with spending on pet supplements growing at approximately 5.9% annually. The StemPets™ product line is positioned to capitalize on this trend with its advanced formulation and scientific backing. Financial Impact and Growth Strategy For Full Alliance Group and its subsidiary Pure Solutions, the manufacturing agreement is expected to contribute significantly to revenue growth in the coming quarters. While specific financial terms were not disclosed, company officials indicated the initial production agreement spans multiple years. The company anticipates that the Stemtech partnership will drive facility utilization rates higher while creating economies of scale that benefit Pure Solutions' overall manufacturing operations. Additional staff hiring is planned to support the increased production demands. Product Innovation and Development StemPets™ represents the culmination of extensive research and development efforts by Stemtech to adapt their stem cell nutrition technology for companion animals. The product formulation includes a proprietary blend of natural ingredients that have been shown to support the release and activity of adult stem cells in animals. Pure Solutions' technical team worked closely with Stemtech's scientists to ensure the manufacturing process preserves the integrity of these specialized ingredients. The collaboration included extensive testing and validation protocols to confirm product efficacy and stability. The initial StemPets™ product line includes formulations for dogs and cats. Pure Solutions' flexible manufacturing capabilities will accommodate this expanding product line as new formulations are introduced. About Full Alliance Group, Inc. Full Alliance Group, Inc. (OTC:FAGI) is a holding company in the health and wellness sector. FAGI's wholly owned subsidiary, Bio Lab Naturals, Inc., founded in 2000, through its FDA-registered wholly owned subsidiary Pure Solutions, Inc., was built on the simple principles of using the highest quality ingredients, producing products with the greatest possible efficacy, and providing its partners with unsurpassed customer service all at a fair price. From day one, the Company has specialized in custom product development and FDA-compliant contract manufacturing, with a passion for cutting-edge formulations and innovative product selection. Now housed in a state-of-the-art 25,000 square foot facility in Tampa, Pure Solutions remains committed to its founding principles and is ready to expand its operations through growing organically by adding diversity to its in-house product lines and strategically through joint ventures, partnerships, acquisitions, exclusive manufacturing and distribution agreements, and mergers. About Stemtech Corporation Stemtech Corporation (STEK) is the pioneer in the field of stem cell nutrition, developing innovative products that support the body's natural renewal system. For over 20 years, Stemtech has led the market with science-based formulations that promote wellness through supporting the body's natural stem cell processes. The company's product line includes nutritional supplements for humans and now extends to companion animals with the StemPets™ product line. Forward-Looking Statements This announcement contains forward-looking statements within the meaning of the 'safe harbor' provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, those identified by words such as 'believes,' 'will,' 'expects,' 'anticipates,' 'estimates,' 'intends,' 'plans,' 'targets,' 'projects' and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in these forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, the results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the impact of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, and other risks discussed from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to update any forward-looking statements, or any information contained in this press release or in other public disclosures, at any time. Finally, the investing public is reminded that only announcements or information about Stemtech Corporation disseminated by the Company and bearing its name are considered official. Media Contact: Full Alliance Group Inc. Investor Relations Gabe Rodriguez, Erelations Group [email protected] (623) 261-9046 For Stemtech Investor Relations Information Contact: Charles S. Arnold, CEO Stemtech Phone: 336-918-0507 Email: [email protected] Stemtech Corporation Phone: +1 954-715-6000 ext 1040 Email: [email protected] SOURCE: Full Alliance Group, Inc. press release
Associated Press
29-05-2025
- Business
- Associated Press
Full Alliance Group, Inc. (OTC:FAGI) Through its Joint Venture Companies FV Products International, LLC and Aquaox Pure Solutions, LLC Launches Jusspray(TM): Innovative Skin-Safe Sanitizing Mist
TAMPA, FL / ACCESS Newswire / May 29, 2025 / Aquaox Pure Solutions LLC, a leader in science-backed wellness, today announced the commercial rollout of Jusspray™, a breakthrough topical and surface sanitizing spray. This innovative product delivers hospital-grade germ protection without harsh chemicals, setting a new standard in the sanitizing industry. Manufactured exclusively at The Aquaox Pure Solutions manufacturing facility in Tampa, Florida, Just Spray™ is now available online at and through Pure Solutions' established network of specialty health and beauty retailers. William Heneghan, COO of Pure Solutions, stated, 'Our first shipment went straight to the independent and regional stores that have supported us for years. These partners value clean formulations and sustainability as much as we do, making them the ideal launchpad for Jusspray™.' A New Paradigm in Sanitization Jusspray™ stands out in the crowded sanitizer market with its unique combination of efficacy and skin-friendliness. Key benefits include: These features make Jusspray™ suitable for a wide range of applications, from sanitizing hands and personal devices to cleaning gym equipment and shopping carts. Its gentle formulation ensures no stinging, dryness, or overpowering odor, making it safe for sensitive skin and children. Manufacturing Excellence: Made in Tampa, FL All production, filling, and quality assurance processes for Jusspray™ occur at The Aquaox Pure Solutions Tampa facility. This state-of-the-art manufacturing center has expanded to produce up to 1,750 gallons a day of HOCl and will have a capacity of over 5,000 gallons a day by the end of July 2025. Michel Van Schaik, emphasized the company's commitment to quality and sustainability: 'From day one, our plan has been measured growth anchored by quality partnerships. The interest from distributors and retailers looking to put their own brand on our hypochlorous technology affirms the product's broad appeal.' Strategic Market Approach Pure Solutions is implementing a multi-faceted go-to-market strategy for Jusspray™: Industry Impact and Future Outlook The launch of Jusspray™ represents a significant advancement in the sanitization industry. By combining hospital-grade effectiveness with skin-safe, eco-friendly formulation, Pure Solutions is addressing a growing consumer demand for products that protect both personal and environmental health. As the sanitization market continues to evolve in response to global health concerns, products like Jusspray™ are positioned to lead the next wave of innovation. The potential for private-label partnerships with major retailers suggests a bright future for Aquaox Pure Solutions technology. About Full Alliance Group, Inc. Full Alliance Group, Inc. (OTC:FAGI) is a holding company focused on the health and wellness sector. Through its FDA-registered subsidiary Pure Solutions, Inc. (founded 2000), the company specializes in custom product development and FDA-compliant contract manufacturing. Operating from a state-of-the-art 25,000 sq ft facility in Tampa, Pure Solutions is expanding both organically and through joint ventures, acquisitions, and exclusive manufacturing and distribution agreements. About Aquaox Pure Solutions, LLC Aquaox Pure Solutions, LLC is a leading manufacturer of hypochlorous-acid products enhanced with nanobubble technology. Committed to sustainability and efficacy, Aquaox Pure Solutions serves diverse markets from healthcare to consumer goods. Media Contact Full Alliance Group Inc. Investor Relations Gabe Rodriguez, Erelations Group [email protected] | (623) 261-9046 Aquaox Pure Solutions, LLC Brett Phillips [email protected] | (800) 895-4415 Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than historical facts-including, but not limited to, statements regarding future financial performance, business strategy, and plans and objectives for future operations-are forward-looking and involve risks, uncertainties, and factors that may cause actual results to differ materially from those anticipated. SOURCE: Full Alliance Group, Inc. press release
Associated Press
29-04-2025
- Business
- Associated Press
RETRANSMISSION: Full Alliance Group, Inc. (OTC: FAGI) Establishes Aquaox Pure Solutions, LLC to Revolutionize Hypochlorous Acid Production with Nanobubble Technology
TAMPA, FL / ACCESS Newswire / April 29, 2025 / Full Alliance Group, Inc. (OTC:FAGI) today announced the formation of its wholly owned subsidiary, Aquaox Pure Solutions, LLC. The new entity will manufacture pure hypochlorous acid (HOCl) utilizing advanced nanobubble technology, positioning the company to set new standards in efficacy and safety across multiple industries including healthcare, agriculture, water treatment, and consumer products. Michel Van Schaik, a globally recognized expert in hypochlorous acid manufacturing with over three decades of experience, has been appointed President of Aquaox Pure Solutions. His extensive background as a distinguished chemist and pioneer in environmentally friendly HOCl solutions will be instrumental in driving the subsidiary to the forefront of the industry. 'Joining forces with Full Alliance Group allows us to scale our innovative HOCl solutions more effectively,' stated Van Schaik. 'Our commitment to quality and sustainability aligns seamlessly with Full Alliance's vision, and together, we aim to set new benchmarks in the industry.' Revolutionary Nanobubble Technology Aquaox Pure Solutions' competitive advantage lies in its implementation of cutting-edge nanobubble technology. This innovation enhances the stability and effectiveness of hypochlorous acid by infusing microscopic gas-filled cavities into HOCl solutions, significantly improving penetration capabilities and extending shelf life. The result is a superior antimicrobial product that meets the rigorous demands of various industries. The company's manufacturing processes create pure HOCl that maintains its efficacy without the addition of artificial stabilizers, preservatives, or harmful chemicals. This approach ensures products that are both highly effective and environmentally responsible. The Science Behind Hypochlorous Acid Hypochlorous acid is a naturally occurring compound produced by the human immune system to combat pathogens. It has gained significant attention in recent years due to its potent antimicrobial properties that effectively neutralize bacteria, viruses, and fungi. Unlike traditional chemical disinfectants, HOCl is non-toxic and gentle on human tissues while remaining highly effective against pathogens. Research published in numerous scientific journals has documented HOCl's efficacy in promoting skin health and accelerating wound healing. Its unique properties make it suitable for applications ranging from medical wound care to food-safe sanitation solutions, addressing growing market demand for effective yet gentle antimicrobial products. Strategic Market Focus: Direct-to-Consumer HOCl Applications PureAquaox Solutions is committed to manufacturing premium HOCl products specifically for the direct-to-consumer market, addressing growing demand in skin care, cleansers, topical solutions, and disinfectants. Our advanced production facility is uniquely positioned to be a global leader in the delivery of HOCl in five-gallon-or-less packaging, ensuring convenient access to high-quality solutions for consumers and businesses alike. To support emerging and established brands, we provide drop shipping services and white-label opportunities, allowing businesses to customize and market their own HOCl-based products efficiently. This approach enables e-commerce brands, retailers, and private-label enterprises to expand their offerings in the rapidly growing HOCl market, meeting the increasing demand for safe, effective, and eco-friendly antimicrobial solutions. 'The demand for high-purity, environmentally friendly antimicrobial solutions is growing exponentially,' said Michel Van Schaik, CEO of PureAquaox Solutions. 'Our state-of-the-art facility is uniquely positioned to deliver premium HOCl products in various consumer-friendly formats. By leveraging our advanced nanobubble technology, we can provide industry-leading stability and efficacy, ensuring our partners and consumers receive the highest quality solutions available.' Synergistic Business Integration The establishment of Aquaox Pure Solutions represents a strategic alignment of resources and expertise between the new subsidiary and Full Alliance Group. The partnership capitalizes on existing manufacturing capacity while expanding production capabilities for innovative HOCl products. Bill Heneghan, COO of Full Alliance Group, Inc., emphasized the strategic timing of the venture: 'It was an incredible timing opportunity for Full Alliance. We were looking to sublease some of our underutilized square footage, and Mr. Van Schaik was looking to expand his main operations in Tampa, FL. It was a perfect fit, and he has been instrumental in creating additional opportunities for our subsidiaries as well as the clients we manufacture for. By introducing such an incredible product with so many applications-and one that truly works-we anticipate the division to do very well. We have developed unique SKUs tailored for the direct selling industry, as well as our e-commerce direct-to-consumer initiatives, positioning us for strong and sustainable growth.' The collaboration provides Full Alliance Group with enhanced vertical integration in its manufacturing operations while creating new revenue streams through specialized product development. The company anticipates significant market penetration in both B2B and direct-to-consumer channels. Environmental Commitment Aquaox Pure Solutions has established strict manufacturing standards that align with growing consumer demand for sustainable products. The company's HOCl solutions are free from added scents, colors, or dyes, making them suitable for sensitive applications while minimizing environmental impact. The production process itself has been engineered to reduce resource consumption and minimize waste generation. By utilizing energy-efficient equipment and implementing water conservation measures, PureAquaox demonstrates environmental stewardship throughout its operations. Furthermore, the company's formulations break down into simple, non-toxic components after use, preventing the accumulation of harmful residues in water systems and soil-a significant advantage over many traditional chemical sanitizers and disinfectants. Market Outlook and Growth Strategy The global market for hypochlorous acid products is experiencing rapid expansion across multiple sectors. Industry analysts project continued growth driven by increasing awareness of HOCl's efficacy and safety advantages over conventional chemical alternatives. Aquaox Pure Solutions has developed a multi-phase growth strategy focused on expanding its presence in the direct-to-consumer skincare and topical wellness market while leveraging its proven success in the medical, agriculture, and water treatment industries. The strategy includes: With Aquaox's established expertise in medical, agriculture, and water treatment applications, this strategic expansion into direct-to-consumer skincare and wellness positions the company for significant growth while introducing consumers to the transformative benefits of HOCl-based solutions. With the establishment of Aquaox Pure Solutions, Full Alliance Group is strategically positioned to capitalize on growing market demand for effective, non-toxic antimicrobial products across multiple industries. The integration of nanobubble technology under the leadership of Michel Van Schaik enables the company to address evolving market needs with innovative, sustainable solutions. Media Contact: Full Alliance Group Inc. Investor Relations Gabe Rodriguez, Erelations Group [email protected] (623) 261-9046 Pure Aquaox Solutions, LLC Brett Phillips [email protected] (800) 895-4415 About Full Alliance Group, Inc. Full Alliance Group, Inc. (OTC: FAGI) is a holding company in the health and wellness sector. FAGI's wholly owned subsidiary, Bio Lab Naturals, Inc., founded in 2000, through its FDA-registered wholly owned subsidiary Pure Solutions, Inc., was built on the simple principles of using the highest quality ingredients, producing products with the greatest possible efficacy, and providing its partners with unsurpassed customer service all at a fair price. From day one, the Company has specialized in custom product development and FDA-compliant contract manufacturing, with a passion for cutting-edge formulations and innovative product selection. Now housed in a state-of-the-art 25,000 square foot facility in Tampa, Pure Solutions remains committed to its founding principles and is ready to expand its operations through growing organically by adding diversity to its in-house product lines and strategically through joint ventures, partnerships, acquisitions, exclusive manufacturing and distribution agreements, and mergers. About Aquaox Pure Solutions, LLC Aquaox Pure Solutions, LLC is a leading manufacturer of hypochlorous acid products enhanced with nanobubble technology. Committed to sustainability and efficacy, PureAquaox serves diverse markets with applications ranging from healthcare to consumer products. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including but not limited to statements regarding future financial performance, business strategy, and plans and objectives for future operations. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such forward-looking statements. SOURCE: Full Alliance Group, Inc. press release
